In depth
Polymyalgia rheumatica and diet
There's no polymyalgia rheumatica diet at all, and one has never been tested. What exists instead is a corticosteroid guideline, along with one vitamin D finding that's worth reading with real care. Neither of those came out of a study of what people with this illness eat day to day.
What the research found.
The 2017 American College of Rheumatology guideline covers every adult on a long corticosteroid course, at every age. It strongly advises four things, which are getting your calcium and vitamin D right and doing weight-bearing and strength-building exercise. The other two are stopping smoking and cutting back on how much you drink.
At the start, vitamin D in polymyalgia rheumatica patients matched the controls, at 21.6 against 22.7 ng/mL. The three-month change is where the two groups split apart from each other. In people whose illness went quiet it rose 22.02 ng/mL, and in people whose illness stayed active it rose 1.33.
In that study the vitamin D rise predicted going quiet, at an odds ratio of 2.89 for remission. Two other things didn't predict anything at all in the group. Neither the prednisone dose nor the total corticosteroid taken over time said anything about who would go on to settle.
One study measured bone density in 198 patients with polymyalgia rheumatica, giant cell arteritis, and other kinds of vasculitis. Neither their current corticosteroid dose nor their total dose correlated with their lowest bone score. Three other things did, which are being lighter, having broken a bone in the spine before, and taking a heartburn drug.
There is no polymyalgia rheumatica diet
No diet trial has been run in polymyalgia rheumatica, and the treatment guidelines give no diet advice. Our record for them notes something else as well, which is that they give no calcium advice and no vitamin D advice either. That's a striking blank in an illness treated with months or years of corticosteroids.
Say that plainly, because the space gets filled anyway. Advice about eating to calm swelling in polymyalgia rheumatica goes around widely, and it rests on no study done in this illness. It's borrowed from rheumatoid arthritis or from general nutrition writing, and usually the borrowing goes unmentioned.
What does apply reaches almost everybody with this diagnosis, and it comes through the treatment rather than the disease. Long corticosteroid courses bring a guideline of their own. That guideline is specific, and if you read only one document it should be that one.
The guideline that reaches you through the prednisone
The 2017 American College of Rheumatology guideline covers every adult starting or staying on a long corticosteroid course. It gives strong advice at every age, starting with calcium and vitamin D. It says how to change how you live too, which is weight-bearing and strength-building exercise, stopping smoking, and drinking less. Those five come together as one recommendation rather than a menu to choose from.
That's the most concrete diet advice available to anyone with this illness, and it says to get your intake right. It names no dose, and this page won't supply a figure the guideline withholds. A calcium or vitamin D dose typed from memory is the kind of invented number this site exists to avoid, so ask whoever prescribes your corticosteroids for the figure they use.
Ask at the start of treatment, because the advice applies from the day a long course begins. Bone loss on corticosteroids runs fastest in the early months. So when that conversation happens counts for more than how long it takes.
The vitamin D finding, and what it can't show
One study of vitamin D in polymyalgia rheumatica produced a result that deserves careful reading. At the start, levels in patients matched the controls, at 21.6 against 22.7 ng/mL. The three-month change is where the groups split, because vitamin D rose 22.02 ng/mL in people whose illness went quiet and 1.33 in people whose illness stayed active. Work through the numbers together, that rise predicted going quiet at an odds ratio of 2.89, while neither the prednisone dose nor the total corticosteroid taken predicted anything.
That's an interesting finding, and it's also a study that looked backward and only watched. So it can't tell you whether raising the level brings the calm spell. Maybe people whose illness settles absorb vitamin D differently, or store it differently, or got prescribed it without a break. Every one of those explanations fits the figures just as well.
So the useful conclusion is a simple one, which is to measure rather than assume. This diagnosis on its own isn't a reason to expect a low vitamin D level, and it isn't a reason to rule one out either. The number is cheap to get and the guess is worth nothing.
Bones, weight, and the things that did track
The link between corticosteroid dose and bone density is less direct than most people are led to expect. One study measured 198 patients with polymyalgia rheumatica, giant cell arteritis, and other kinds of vasculitis, where the dose didn't correlate with the lowest bone score. Neither the current dose nor the total correlated with it, though three other things did. Those were being lighter, having broken a bone in the spine before, and taking a heartburn drug.
That first one cuts against a common instinct, because people gaining weight on corticosteroids often want to cut back sharply. Being lighter was associated with lower bone density in that group. So approach weight thoughtfully rather than aggressively, and that goes double in older patients, who are already losing muscle without trying.
Weight turns up in one other place worth knowing about, because bad tiredness in this illness was associated with more weight and more body fat. It also correlated with worry, low mood, disease activity, the blood markers, pain, and stiffness. That's a link found by watching rather than proof that losing weight cuts tiredness, and it argues against treating corticosteroid weight gain as only about how you look.
What to do while the research is missing
Start from the guideline that applies, which means calcium, vitamin D, weight-bearing exercise, no smoking, and moderate alcohol. Those five are strongly advised together for anyone on a long course. They're also the only diet and lifestyle advice for this illness that has a document behind it at all.
Get your vitamin D measured before you assume anything, because in the better study levels in these patients matched the controls. So the assumption that everyone with polymyalgia rheumatica is short of it isn't supported. Treating a number you never took is how supplements get taken for years without a reason.
Be doubtful about anything sold as a diet for this diagnosis. The whole diet literature in polymyalgia rheumatica is one vitamin D study and no trial of any diet at all. A confident program here is up against nothing at all, which is a low bar rather than a recommendation.
Common misconceptions.
Myth. There's an anti-inflammatory diet for polymyalgia rheumatica.
Reality. One has never been tested, and the treatment guidelines for this illness give no diet advice at all. They give no calcium or vitamin D advice either, which is odd for an illness treated with long corticosteroid courses. So anything sold as a diet here is being sold ahead of the evidence.
Myth. Vitamin D supplementation will get me into remission.
Reality. One study looked back at records, where vitamin D rose 22.02 ng/mL over three months in people whose illness went quiet and 1.33 in people whose illness stayed active. That rise predicted going quiet, at an odds ratio of 2.89. The study looked backward and only watched, so it can't say which caused which. Fixing a low level is worth doing for your bones on corticosteroids, and expecting it to bring the calm spell goes past what that study shows.
Myth. Everyone with polymyalgia rheumatica is vitamin D deficient.
Reality. Not everyone, and the one decent study on this question says so. Levels at the start matched the controls, at 21.6 against 22.7 ng/mL, which is no real difference between the groups. So a low level in this illness is something to measure rather than something to assume about yourself. Ask for the number before you start a supplement, because a diagnosis on its own has never been a good reason to take one.
Myth. If my steroid dose is low, my bones are safe.
Reality. Not necessarily, because in a study of 198 patients on these drugs the corticosteroid dose didn't correlate with bone density. Neither the current dose nor the total told you anything. Three other things did, which were being lighter, having broken a bone in the spine before, and taking a heartburn drug. That study looked at people at one moment, most already on bone protection, so it can't replace a trial.
Cautions specific to this condition.
- Ask about bone protection at the start of corticosteroid treatment, not months in. The guideline applies from the day a long course begins.
- Mention any heartburn drug you take. It was one of the three things associated with lower bone density in the study of 198 patients.
- Watch your weight during corticosteroid treatment. Bad tiredness in this illness was associated with more weight and more body fat.
- Get your vitamin D measured, because assuming it's low is how people end up taking something they don't need. In the better study, levels in these patients matched the controls.
- Talk about calcium from food before you reach for a supplement. The guideline says to get your intake right, and it names no product.
- Losing weight you didn't mean to lose while on corticosteroids is a reason to get checked rather than a reason to be pleased. It's worth mentioning at a visit.
Discuss any change with the rheumatologist who manages your care. Nothing here replaces that conversation.
Questions patients ask.
Is there a diet for polymyalgia rheumatica?
There isn't one, and one has never been tested. The treatment guidelines for this illness give no diet advice, and no calcium or vitamin D advice either, and our source record says so outright. Read that correctly, because it's a blank in the evidence and not evidence that eating well doesn't help. What it does mean is that confident diet advice you get for this diagnosis isn't coming from a study in it.
So what does apply to me?
The corticosteroid guideline does, and it reaches you through your treatment rather than through your diagnosis. The 2017 American College of Rheumatology guideline covers every adult starting or staying on a long corticosteroid course. It strongly advises getting your calcium and vitamin D right, doing weight-bearing and strength-building exercise, stopping smoking, and cutting back on alcohol. Between them those cover nearly everyone with this illness.
What's the vitamin D finding I keep hearing about?
One study looked back at patient records, where vitamin D rose 22.02 ng/mL over three months in people whose illness went quiet and 1.33 in people whose illness stayed active. That rise predicted going quiet, at an odds ratio of 2.89. Two other things predicted nothing, which were the prednisone dose and the total corticosteroid taken over time. It's a striking result, and it also looked backward and only watched, so it can't show which caused which.
Should I take a vitamin D supplement?
If you're on a long corticosteroid course, the guideline says to get your intake right, and that's a fair reason on its own. What the evidence doesn't back is taking it to drive your illness quiet, however suggestive that backward-looking study is. Get a level measured, because guessing at what it might be gets you nowhere useful. In the better study, levels in these patients matched the controls.
Am I likely to be deficient?
Don't assume it either way, because the one decent study here found levels at the start matched the controls. Those were 21.6 in patients against 22.7 ng/mL. That's no real difference at all, so this diagnosis on its own isn't a reason to expect a low level in you. Ask for the number instead, because measuring is cheap and guessing at it is not useful.
Will diet protect my bones on prednisone?
Calcium and vitamin D are named in the guideline. What happens with the dose is less predictable than most people expect, because in 198 patients on these drugs the corticosteroid dose didn't correlate with bone density at all. Neither the current dose nor the total correlated with it, though three other things did, which were being lighter, having broken a bone in the spine before, and taking a heartburn drug. So being underweight is a risk here, and that's worth knowing before you start any strict diet.
Does weight play a part in this condition?
It turns up in one place worth knowing about, where bad tiredness in polymyalgia rheumatica was associated with more weight and more body fat. It also correlated with worry, low mood, disease activity, the blood markers, pain, and stiffness in those patients. That's a link found by watching rather than proof that losing weight cuts tiredness, and it's a reason not to treat corticosteroid weight gain as only about how you look.
References.
- Buckley L; Guyatt G; Fink H et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis. Arthritis & Rheumatology. 2017;69:1521-1537. 10.1002/art.40137GRADE-based clinical practice guideline
- Hysa E; Balito S; Davoli G et al. Vitamin D Status and Response to Supplementation as Predictive Factors for Early Remission in Polymyalgia Rheumatica: A Retrospective Longitudinal Investigation. Nutrients. 2025;17:2839. 10.3390/nu17172839Retrospective observational case-control study with a longitudinal subgroup
- Palmowski A; Wiebe E; Muche B et al. Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides—Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort. Cells. 2022;11:536. 10.3390/cells11030536Cross-sectional baseline analysis of a prospective cohort
- Dejaco C; Singh Y; Perel P et al. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Annals of the Rheumatic Diseases. 2015;74:1799-1807. 10.1136/annrheumdis-2015-207492International guideline
- Leung J; De Ross B; Gianoudis J et al. More Than Pain and Stiffness: Persistent Fatigue and Sleep Disturbance in Polymyalgia Rheumatica. The Journal of Rheumatology. 2025:jrheum.2024-0980. 10.3899/jrheum.2024-0980Prospective longitudinal case-control cohort
This page gathers the published research on this subject into one place. The studies behind it were published between 1989 and 2026, and every figure links to the paper it came from. Those studies were peer reviewed. This summary of them was not. Dr. Sarah Luebker is reviewing these pages one at a time and has not reached this one yet, so it carries no medical review date and nothing here is her opinion or her advice to you. Each page gets updated as she reaches it. It is here in the meantime because the science is worth having in one organized place that is easy to find and easy to read. Talk to your own clinician before acting on any of it.